Literature DB >> 26334501

Risk Management for Materials and Components Used in Orally Inhaled and Nasal Drug Products.

Cheryl L M Stults1, Gaby Reckzuegel2, Arthur Bailey3, Jonathan Petersen4, Lisa Dick5, Thomas Feinberg6, Andrew Feilden7, Sara Miller5, James Connors8, Lee M Nagao9.   

Abstract

Keywords:  container closure systems; nasal products; orally inhaled products; packaging; risk management

Mesh：

Substances：

Year:  2015        PMID： 26334501     DOI： 10.1007/s11095-015-1770-7

Source DB:  PubMed          Journal:  Pharm Res        ISSN： 0724-8741            Impact factor:   4.200


× No keyword cloud information.
  2 in total

1.  The increased incidence of pure red cell aplasia with an Eprex formulation in uncoated rubber stopper syringes.

Authors:  Katia Boven; Scott Stryker; John Knight; Adrian Thomas; Marc van Regenmortel; David M Kemeny; David Power; Jerome Rossert; Nicole Casadevall
Journal:  Kidney Int       Date:  2005-06       Impact factor: 10.612

2.  Advancing the field of pharmaceutical risk minimization through application of implementation science best practices.

Authors:  Meredith Y Smith; Elaine Morrato
Journal:  Drug Saf       Date:  2014-08       Impact factor: 5.606
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.